(HealthDay): Fifty-five percent of children, adolescents, and young adults with hematologic malignancies experience high-intensity end-of-life care (HI-EOLC), with a higher likelihood of being treated in medium or large hospitals, according to a study published online June 29 a Cancer.
Sophia Mun, MPH, of the Yale Center for Research on Cancer Outcomes, Public Policy, and Efficacy in New Haven, Connecticut, and colleagues conducted a population-based retrospective cohort study with individuals with hematological malignancies from 0 to 39 years at death, who died between 2010 and 2017. The patient’s sociodemographic and hospital characteristics associated with HI-EOLC were examined.
The researchers found that 55% of the 1,454 deceased experienced HI-EOLC. The likelihood of receiving HI-EOLC was increased in patients treated in medium or large hospitals (adjusted probabilities, 1.63 and 2.21, respectively), insured by Medicaid (adjusted probabilities, 1.40), or receiving targeted treatment. against cancer in the Northeast (adjusted odds ratio, 1.50).
“The type of insurance, the size of the hospital, and the hospital region appear to significantly influence HI-EOLC reception,” the authors write. “Mitigation strategies may include a previous integration of palliatives and / or hospital care when feasible, as well as a policy change that allows for interventions such as transfusions in outpatient settings. “
One author revealed financial links with the biopharmaceutical industry.
Summary / Full text (subscription or payment may be required)
Copyright © 2021 HealthDay. All rights reserved.
Citation: Many young people with blood cancer receive intensive care at the end of life (2021, July 6) recovered on July 6, 2021 at https://medicalxpress.com/news/2021-07-youth-blood-cancers- intensive-end-of -life.html
This document is subject to copyright. Apart from any fair treatment for the purposes of private study or research, no part may be reproduced without written permission. Content is provided for informational purposes only.